Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $408.00
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price target upped by Royal Bank of Canada from $407.00 to $408.00 in a research note issued to investors on Thursday,Benzinga reports. Royal Bank of Canada currently has a sector perform rating on the pharmaceutical company’s stock. A number of other research analysts have also issued reports […]
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price target upped by Royal Bank of Canada from $407.00 to $408.00 in a research note issued to investors on Thursday,Benzinga reports. Royal Bank of Canada currently has a sector perform rating on the pharmaceutical company’s stock. A number of other research analysts have also issued reports […]
